Clinical trials
Alzheimer Disease or Associated Disorder clinical trials
Below are recruiting alzheimer disease or associated disorder clinical trials, each written for real people, not researchers. We’re tracking 1,816 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06649500Recruiting
Comparing two balance therapy methods for older adults
This trial tests whether a high-tech treadmill (Walker View) or group therapy works better for improving balance and preventing falls in older adults. It also uses artificial intelligence to predict fall risk early.
Rome, RomeAges 65 years+ - NCT07460947RecruitingPhase 1/Phase 2
One-day TMS and medicine for suicidal thoughts in BPD
This trial tests if a single day of accelerated transcranial magnetic stimulation (TMS) combined with the medication D-cycloserine can reduce suicidal thoughts in people with borderline personality disorder (BPD). It aims to find a fast-acting treatment option for those who are struggling.
Belmont, MassachusettsAges 18 years+ - NCT07656415RecruitingPhase 3
Study of mitapivat for sickle cell disease patients who need blood transfusions
This study tests whether a daily pill called mitapivat can reduce the number of blood transfusions you need. It is for people with sickle cell disease who have had at least one transfusion in the past year and are not on regular transfusion therapy.
Indianapolis, IndianaAges 12 years+ - NCT07368972RecruitingPhase 2
Study of DISC-0974-201 for IBD and Anemia
This trial tests a new medicine called DISC-0974-201 for people with inflammatory bowel disease and anemia. It aims to see if the drug can improve anemia symptoms and is for people with mild disease activity who have not responded well to standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT05884853Recruiting
Social brain training for adults with autism
This study tests a brain training program for adults with autism to see if it improves social skills. It may help participants understand social situations better.
Taipei, Zhongzheng Dist.Ages 18–50 - NCT05157477Recruiting
Addressing sensory issues in adults with autism
This study tests a virtual reality program to help adults with autism cope with sensory problems and improve social skills. Participants will practice handling sensory situations in a safe VR environment.
TaipeiAges 20–45 - NCT07013916Recruiting
Fructose and liver health in fatty liver disease
This study looks at how a sugar called fructose affects inflammation and metabolism in people with a type of fatty liver disease called MASH. It aims to find out if fructose plays a role in making the disease worse.
LondonAges 45–65 - NCT05857813Recruiting
Social skills group training for teens with autism
This trial tests a structured social skills training group for adolescents with autism spectrum disorder (ASD) to improve day-to-day social functioning. It involves both the teen and a Chinese-speaking caregiver who helps support the training at home.
TaipeiAges 11–20 - NCT06816511Enrolling by invitation
Focused ultrasound study for hard-to-treat OCD
This trial tests if a non-invasive ultrasound treatment can help people with obsessive-compulsive disorder (OCD) that hasn't improved with standard therapies. You must have had OCD for at least five years, have severe symptoms, and have tried multiple medications and cognitive-behavioral therapy without enough benefit.
TaipeiAges 18–65 - NCT01500447Recruiting
Study of inherited causes of low puberty hormones
This study looks at families to understand inherited (genetic or family-related) reasons some people have delayed puberty or develop puberty abnormally. It may help doctors better figure out the cause of low sex hormone levels and related hormone problems.
Bethesda, MarylandAges 1 month–120 years - NCT07735182Recruiting
Gut bacteria and organ damage in sepsis
This study looks at how bacteria in your gut and other signs in your body affect liver and kidney damage in people with sepsis. It also compares findings to healthy volunteers to see what is different.
Hangzhou, ZhejiangAges 18 years+ - NCT07330258Recruiting
Observing Parkinson's over time in people still having movement symptoms
This study follows people with Parkinson's disease who still have movement symptoms despite taking medication. It aims to understand how the disease changes over time, which could help improve future treatments.
Phoenix, ArizonaAges 45–75 - NCT03258658RecruitingPhase 1
Testing a personalized urethra repair made from your own tissue
This early study tests whether an engineered urethral patch made from your own body tissue is safe and workable for urethral strictures (narrowing that blocks urine flow). It is mainly looking for safety and how feasible the procedure and follow-up are, not proven cure yet.
San Francisco, CaliforniaAges 21–75 - NCT07717723Recruiting
Support for caregivers of heart disease patients
This study tests a program to help caregivers of people with heart disease manage stress and challenges. It aims to support your mental health while caring for a loved one.
Sacramento, CaliforniaAges 18 years+ - NCT07559500RecruitingPhase 1
Study of tirzepatide for alcohol use disorder
This trial tests if tirzepatide, a diabetes drug, affects brain chemistry linked to alcohol use. Researchers want to see if it can help people with mild-to-moderate alcohol use disorder who also have tried stimulants.
Bethesda, MarylandAges 21–65 - NCT05031507Recruiting
Study of bone disorders and inherited genetic factors
This study looks at bone (skeletal) disorders to better understand possible genetic causes, especially when phosphate levels or bone growth are affected. You may join either if you (or your child) has a bone disorder, or if you’re an unaffected family member who might help compare results.
Bethesda, MarylandAges 2 months–100 years - NCT07710157RecruitingPhase 2
Obinutuzumab for first episode of minimal change disease
This trial tests if obinutuzumab, a targeted therapy, can safely and effectively treat adults with their first episode of minimal change disease (MCD), a kidney condition causing protein leakage. Participants will receive the drug to see if it reduces protein in urine and improves symptoms.
GrazAges 18 years+ - NCT06269627RecruitingPhase 4
Brain activity study for alcohol use treatment
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Bethesda, MarylandAges 21–65 - NCT07610369RecruitingPhase 2
Psilocybin therapy for depression in Parkinson's disease
This study tests whether psilocybin (a psychedelic compound) combined with therapy can reduce depression in people with Parkinson's disease. If you have moderate-to-severe depression and Parkinson's, this trial may offer a new treatment option.
New Haven, ConnecticutAges 40–80 - NCT07420283RecruitingPhase 2
Study of Brenipatide for opioid use disorder
This trial tests a new medicine called Brenipatide for people with opioid use disorder who are already taking buprenorphine but still occasionally use non-prescribed opioids. It aims to see if the study drug can help reduce opioid use.
Phoenix, ArizonaAges 18–75 - NCT07216872Recruiting
Deep TMS to reduce heavy drinking in alcohol use disorder
This trial tests a non-invasive brain stimulation device (Deep TMS) to help people with alcohol use disorder reduce or stop heavy drinking. It uses magnetic pulses to target brain areas linked to addiction.
Tuscaloosa, AlabamaAges 18–86 - NCT07446478Recruiting
TIS for improving thinking problems in schizophrenia
This trial tests if a brain stimulation technique called transcranial electrical stimulation (TIS) can help improve cognitive problems (like memory and attention) in people with schizophrenia. You may join if you are between 18 and 50, have had schizophrenia for no more than 8 years, take 1-2 antipsychotic medicines, and have some trouble with daily activities.
Changsha, HunanAges 18–50 - NCT06247839RecruitingPhase 3
Psilocybin for depression: changing self-focus
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
Charlestown, MassachusettsAges 18–55 - NCT06911229Recruiting
Walking and freezing study for Parkinson's with DBS
This study looks at how the brain controls walking and freezing of gait in people with Parkinson's disease who have deep brain stimulation (DBS). It aims to help understand why freezing happens and improve treatments.
Gainesville, FloridaAges 18–80
Hear when a new Alzheimer Disease or Associated Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alzheimer disease or associated disorder?
- Yes. Clin2 currently lists 1,816 recruiting alzheimer disease or associated disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alzheimer disease or associated disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alzheimer disease or associated disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.